Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Age: Adults
Dose: Intravenous infusion – Initial dose of 100 mg, followed by 50 mg
Frequency: every 12 hours
Note: Intravenous infusions should be administered over approximately 30 to 60 minutes every 12 hours. The duration of therapy should be guided by the severity and site of the infection and the patient's clinical and bacteriological progress.
Indication: Complicated skin and skin structure infections
Age: Adults
Dose: Intravenous infusion – Initial dose of 100 mg, followed by 50 mg
Frequency: every 12 hours
Duration: 5 to 14 days
Note: Intravenous infusions should be administered over approximately 30 to 60 minutes every 12 hours.

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: No approved pediatric dosage available
Note: No approved pediatric dosage available

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment
Dose: Not mentioned – No dosage adjustment needed.
Note: Renal impairment: No dosage adjustment needed.
Administration
  • Must be administered by healthcare professional
  • Infuse over 30-60 minutes
Side Effect

Drug Interaction

Drug NameRisk Factors
Warfarin
Increased serum levels
Oral contraceptives
May decrease efficacy

Disease Interaction

Disease NameRisk Factors
Hypersensitivity
Severe allergic reactions
Hospital-Acquired Pneumonia
Not effective for treatment

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Prior to reconstitution, Tigecycline should be stored at 20°C to 25°C. Once reconstituted, Tigecycline may be stored at room temperature for up to 24 hours (up to 6 hours in the vial and the remaining time in the intravenous bag). Reconstituted solution may be stored refrigerated at 2°C to 8°C for up to 48 hours following immediate transfer of reconstituted solution into the intravenous bag.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.